 | • レポートコード：D005-00234 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、124ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、先天性心疾患の世界市場を広く調査・分析し、今後の市場展望をまとめております。先天性心疾患の種類別市場規模（薬、植込み型心臓装置、カテーテル手技、開心術、心臓移植）、用途別市場規模（病院、診療所、診断センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott Diagnostics、Covance、Becton Dickinson、Array BioPharma、Boston Scientific、AstraZeneca、Roche、Bio-Rad、BG Medicine、Critical Diagnostics、Mylan、GSK、Merck、Janssen Pharmaceuticals、Medtronic ・地域別グローバル市場分析 2015年-2020年 ・先天性心疾患の北米市場（アメリカ、カナダ、メキシコ） ・先天性心疾患のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・先天性心疾患のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・先天性心疾患の南米市場（ブラジル、アルゼンチン） ・先天性心疾患の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：薬、植込み型心臓装置、カテーテル手技、開心術、心臓移植 ・用途別分析：病院、診療所、診断センター ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Congenital Heart Disease market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Congenital Heart Disease market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Congenital Heart Disease market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Congenital Heart Disease market has been segmented into:
Medications
Implantable heart devices
Catheter procedures
Open-heart surgery
Heart transplant
By Application, Congenital Heart Disease has been segmented into:
Hospitals and clinics
Diagnostic centres
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Congenital Heart Disease market presented in the report. This section sheds light on the sales growth of different regional and country-level Congenital Heart Disease markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Congenital Heart Disease market.
The report offers in-depth assessment of the growth and other aspects of the Congenital Heart Disease market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Congenital Heart Disease Market Share Analysis
Congenital Heart Disease competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Congenital Heart Disease sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Congenital Heart Disease sales, revenue and market share for each player covered in this report.
The major players covered in Congenital Heart Disease are:
Abbott Diagnostics
Covance
Becton Dickinson
Array BioPharma
Boston Scientific
AstraZeneca
Roche
Bio-Rad
BG Medicine
Critical Diagnostics
Mylan
GSK
Merck
Janssen Pharmaceuticals
Medtronic
Table of Contents
1 Congenital Heart Disease Market Overview
1.1 Product Overview and Scope of Congenital Heart Disease
1.2 Classification of Congenital Heart Disease by Type
1.2.1 Global Congenital Heart Disease Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Congenital Heart Disease Revenue Market Share by Type in 2019
1.2.3 Medications
1.2.4 Implantable heart devices
1.2.5 Catheter procedures
1.2.6 Open-heart surgery
1.2.7 Heart transplant
1.3 Global Congenital Heart Disease Market by Application
1.3.1 Overview: Global Congenital Heart Disease Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals and clinics
1.3.3 Diagnostic centres
1.4 Global Congenital Heart Disease Market by Regions
1.4.1 Global Congenital Heart Disease Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Congenital Heart Disease (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Congenital Heart Disease Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Congenital Heart Disease Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Congenital Heart Disease Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Congenital Heart Disease Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Congenital Heart Disease Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott Diagnostics
2.1.1 Abbott Diagnostics Details
2.1.2 Abbott Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Diagnostics SWOT Analysis
2.1.4 Abbott Diagnostics Product and Services
2.1.5 Abbott Diagnostics Congenital Heart Disease Revenue, Gross Margin and Market Share (2018-2019)
2.2 Covance
2.2.1 Covance Details
2.2.2 Covance Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Covance SWOT Analysis
2.2.4 Covance Product and Services
2.2.5 Covance Congenital Heart Disease Revenue, Gross Margin and Market Share (2018-2019)
2.3 Becton Dickinson
2.3.1 Becton Dickinson Details
2.3.2 Becton Dickinson Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Becton Dickinson SWOT Analysis
2.3.4 Becton Dickinson Product and Services
2.3.5 Becton Dickinson Congenital Heart Disease Revenue, Gross Margin and Market Share (2018-2019)
2.4 Array BioPharma
2.4.1 Array BioPharma Details
2.4.2 Array BioPharma Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Array BioPharma SWOT Analysis
2.4.4 Array BioPharma Product and Services
2.4.5 Array BioPharma Congenital Heart Disease Revenue, Gross Margin and Market Share (2018-2019)
2.5 Boston Scientific
2.5.1 Boston Scientific Details
2.5.2 Boston Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Boston Scientific SWOT Analysis
2.5.4 Boston Scientific Product and Services
2.5.5 Boston Scientific Congenital Heart Disease Revenue, Gross Margin and Market Share (2018-2019)
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 AstraZeneca SWOT Analysis
2.6.4 AstraZeneca Product and Services
2.6.5 AstraZeneca Congenital Heart Disease Revenue, Gross Margin and Market Share (2018-2019)
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Roche SWOT Analysis
2.7.4 Roche Product and Services
2.7.5 Roche Congenital Heart Disease Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bio-Rad
2.8.1 Bio-Rad Details
2.8.2 Bio-Rad Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bio-Rad SWOT Analysis
2.8.4 Bio-Rad Product and Services
2.8.5 Bio-Rad Congenital Heart Disease Revenue, Gross Margin and Market Share (2018-2019)
2.9 BG Medicine
2.9.1 BG Medicine Details
2.9.2 BG Medicine Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 BG Medicine SWOT Analysis
2.9.4 BG Medicine Product and Services
2.9.5 BG Medicine Congenital Heart Disease Revenue, Gross Margin and Market Share (2018-2019)
2.10 Critical Diagnostics
2.10.1 Critical Diagnostics Details
2.10.2 Critical Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Critical Diagnostics SWOT Analysis
2.10.4 Critical Diagnostics Product and Services
2.10.5 Critical Diagnostics Congenital Heart Disease Revenue, Gross Margin and Market Share (2018-2019)
2.11 Mylan
2.11.1 Mylan Details
2.11.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Mylan SWOT Analysis
2.11.4 Mylan Product and Services
2.11.5 Mylan Congenital Heart Disease Revenue, Gross Margin and Market Share (2018-2019)
2.12 GSK
2.12.1 GSK Details
2.12.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 GSK SWOT Analysis
2.12.4 GSK Product and Services
2.12.5 GSK Congenital Heart Disease Revenue, Gross Margin and Market Share (2018-2019)
2.13 Merck
2.13.1 Merck Details
2.13.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Merck SWOT Analysis
2.13.4 Merck Product and Services
2.13.5 Merck Congenital Heart Disease Revenue, Gross Margin and Market Share (2018-2019)
2.14 Janssen Pharmaceuticals
2.14.1 Janssen Pharmaceuticals Details
2.14.2 Janssen Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Janssen Pharmaceuticals SWOT Analysis
2.14.4 Janssen Pharmaceuticals Product and Services
2.14.5 Janssen Pharmaceuticals Congenital Heart Disease Revenue, Gross Margin and Market Share (2018-2019)
2.15 Medtronic
2.15.1 Medtronic Details
2.15.2 Medtronic Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Medtronic SWOT Analysis
2.15.4 Medtronic Product and Services
2.15.5 Medtronic Congenital Heart Disease Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Congenital Heart Disease Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Congenital Heart Disease Players Market Share
3.2.2 Top 10 Congenital Heart Disease Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Congenital Heart Disease Revenue and Market Share by Regions
4.2 North America Congenital Heart Disease Revenue and Growth Rate (2015-2020)
4.3 Europe Congenital Heart Disease Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Congenital Heart Disease Revenue and Growth Rate (2015-2020)
4.5 South America Congenital Heart Disease Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Congenital Heart Disease Revenue and Growth Rate (2015-2020)
5 North America Congenital Heart Disease Revenue by Countries
5.1 North America Congenital Heart Disease Revenue by Countries (2015-2020)
5.2 USA Congenital Heart Disease Revenue and Growth Rate (2015-2020)
5.3 Canada Congenital Heart Disease Revenue and Growth Rate (2015-2020)
5.4 Mexico Congenital Heart Disease Revenue and Growth Rate (2015-2020)
6 Europe Congenital Heart Disease Revenue by Countries
6.1 Europe Congenital Heart Disease Revenue by Countries (2015-2020)
6.2 Germany Congenital Heart Disease Revenue and Growth Rate (2015-2020)
6.3 UK Congenital Heart Disease Revenue and Growth Rate (2015-2020)
6.4 France Congenital Heart Disease Revenue and Growth Rate (2015-2020)
6.5 Russia Congenital Heart Disease Revenue and Growth Rate (2015-2020)
6.6 Italy Congenital Heart Disease Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Congenital Heart Disease Revenue by Countries
7.1 Asia-Pacific Congenital Heart Disease Revenue by Countries (2015-2020)
7.2 China Congenital Heart Disease Revenue and Growth Rate (2015-2020)
7.3 Japan Congenital Heart Disease Revenue and Growth Rate (2015-2020)
7.4 Korea Congenital Heart Disease Revenue and Growth Rate (2015-2020)
7.5 India Congenital Heart Disease Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Congenital Heart Disease Revenue and Growth Rate (2015-2020)
8 South America Congenital Heart Disease Revenue by Countries
8.1 South America Congenital Heart Disease Revenue by Countries (2015-2020)
8.2 Brazil Congenital Heart Disease Revenue and Growth Rate (2015-2020)
8.3 Argentina Congenital Heart Disease Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Congenital Heart Disease by Countries
9.1 Middle East & Africa Congenital Heart Disease Revenue by Countries (2015-2020)
9.2 Saudi Arabia Congenital Heart Disease Revenue and Growth Rate (2015-2020)
9.3 UAE Congenital Heart Disease Revenue and Growth Rate (2015-2020)
9.4 Egypt Congenital Heart Disease Revenue and Growth Rate (2015-2020)
9.5 South Africa Congenital Heart Disease Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Congenital Heart Disease Revenue and Market Share by Type (2015-2020)
10.2 Global Congenital Heart Disease Market Forecast by Type (2019-2024)
10.3 Medications Revenue Growth Rate (2015-2025)
10.4 Implantable heart devices Revenue Growth Rate (2015-2025)
10.5 Catheter procedures Revenue Growth Rate (2015-2025)
10.6 Open-heart surgery Revenue Growth Rate (2015-2025)
10.7 Heart transplant Revenue Growth Rate (2015-2025)
11 Global Congenital Heart Disease Market Segment by Application
11.1 Global Congenital Heart Disease Revenue Market Share by Application (2015-2020)
11.2 Congenital Heart Disease Market Forecast by Application (2019-2024)
11.3 Hospitals and clinics Revenue Growth (2015-2020)
11.4 Diagnostic centres Revenue Growth (2015-2020)
12 Global Congenital Heart Disease Market Size Forecast (2021-2025)
12.1 Global Congenital Heart Disease Market Size Forecast (2021-2025)
12.2 Global Congenital Heart Disease Market Forecast by Regions (2021-2025)
12.3 North America Congenital Heart Disease Revenue Market Forecast (2021-2025)
12.4 Europe Congenital Heart Disease Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Congenital Heart Disease Revenue Market Forecast (2021-2025)
12.6 South America Congenital Heart Disease Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Congenital Heart Disease Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Congenital Heart Disease Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Congenital Heart Disease by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Congenital Heart Disease Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Congenital Heart Disease Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Diagnostics Corporate Information, Location and Competitors
Table 6. Abbott Diagnostics Congenital Heart Disease Major Business
Table 7. Abbott Diagnostics Congenital Heart Disease Total Revenue (USD Million) (2017-2018)
Table 8. Abbott Diagnostics SWOT Analysis
Table 9. Abbott Diagnostics Congenital Heart Disease Product and Solutions
Table 10. Abbott Diagnostics Congenital Heart Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Covance Corporate Information, Location and Competitors
Table 12. Covance Congenital Heart Disease Major Business
Table 13. Covance Congenital Heart Disease Total Revenue (USD Million) (2018-2019)
Table 14. Covance SWOT Analysis
Table 15. Covance Congenital Heart Disease Product and Solutions
Table 16. Covance Congenital Heart Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Becton Dickinson Corporate Information, Location and Competitors
Table 18. Becton Dickinson Congenital Heart Disease Major Business
Table 19. Becton Dickinson Congenital Heart Disease Total Revenue (USD Million) (2017-2018)
Table 20. Becton Dickinson SWOT Analysis
Table 21. Becton Dickinson Congenital Heart Disease Product and Solutions
Table 22. Becton Dickinson Congenital Heart Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Array BioPharma Corporate Information, Location and Competitors
Table 24. Array BioPharma Congenital Heart Disease Major Business
Table 25. Array BioPharma Congenital Heart Disease Total Revenue (USD Million) (2017-2018)
Table 26. Array BioPharma SWOT Analysis
Table 27. Array BioPharma Congenital Heart Disease Product and Solutions
Table 28. Array BioPharma Congenital Heart Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Boston Scientific Corporate Information, Location and Competitors
Table 30. Boston Scientific Congenital Heart Disease Major Business
Table 31. Boston Scientific Congenital Heart Disease Total Revenue (USD Million) (2017-2018)
Table 32. Boston Scientific SWOT Analysis
Table 33. Boston Scientific Congenital Heart Disease Product and Solutions
Table 34. Boston Scientific Congenital Heart Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. AstraZeneca Corporate Information, Location and Competitors
Table 36. AstraZeneca Congenital Heart Disease Major Business
Table 37. AstraZeneca Congenital Heart Disease Total Revenue (USD Million) (2017-2018)
Table 38. AstraZeneca SWOT Analysis
Table 39. AstraZeneca Congenital Heart Disease Product and Solutions
Table 40. AstraZeneca Congenital Heart Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Roche Corporate Information, Location and Competitors
Table 42. Roche Congenital Heart Disease Major Business
Table 43. Roche Congenital Heart Disease Total Revenue (USD Million) (2017-2018)
Table 44. Roche SWOT Analysis
Table 45. Roche Congenital Heart Disease Product and Solutions
Table 46. Roche Congenital Heart Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Bio-Rad Corporate Information, Location and Competitors
Table 48. Bio-Rad Congenital Heart Disease Major Business
Table 49. Bio-Rad Congenital Heart Disease Total Revenue (USD Million) (2017-2018)
Table 50. Bio-Rad SWOT Analysis
Table 51. Bio-Rad Congenital Heart Disease Product and Solutions
Table 52. Bio-Rad Congenital Heart Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. BG Medicine Corporate Information, Location and Competitors
Table 54. BG Medicine Congenital Heart Disease Major Business
Table 55. BG Medicine Congenital Heart Disease Total Revenue (USD Million) (2017-2018)
Table 56. BG Medicine SWOT Analysis
Table 57. BG Medicine Congenital Heart Disease Product and Solutions
Table 58. BG Medicine Congenital Heart Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Critical Diagnostics Corporate Information, Location and Competitors
Table 60. Critical Diagnostics Congenital Heart Disease Major Business
Table 61. Critical Diagnostics Congenital Heart Disease Total Revenue (USD Million) (2017-2018)
Table 62. Critical Diagnostics SWOT Analysis
Table 63. Critical Diagnostics Congenital Heart Disease Product and Solutions
Table 64. Critical Diagnostics Congenital Heart Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Mylan Corporate Information, Location and Competitors
Table 66. Mylan Congenital Heart Disease Major Business
Table 67. Mylan Congenital Heart Disease Total Revenue (USD Million) (2017-2018)
Table 68. Mylan SWOT Analysis
Table 69. Mylan Congenital Heart Disease Product and Solutions
Table 70. Mylan Congenital Heart Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. GSK Corporate Information, Location and Competitors
Table 72. GSK Congenital Heart Disease Major Business
Table 73. GSK Congenital Heart Disease Total Revenue (USD Million) (2017-2018)
Table 74. GSK SWOT Analysis
Table 75. GSK Congenital Heart Disease Product and Solutions
Table 76. GSK Congenital Heart Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Merck Corporate Information, Location and Competitors
Table 78. Merck Congenital Heart Disease Major Business
Table 79. Merck Congenital Heart Disease Total Revenue (USD Million) (2017-2018)
Table 80. Merck SWOT Analysis
Table 81. Merck Congenital Heart Disease Product and Solutions
Table 82. Merck Congenital Heart Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Janssen Pharmaceuticals Corporate Information, Location and Competitors
Table 84. Janssen Pharmaceuticals Congenital Heart Disease Major Business
Table 85. Janssen Pharmaceuticals Congenital Heart Disease Total Revenue (USD Million) (2017-2018)
Table 86. Janssen Pharmaceuticals SWOT Analysis
Table 87. Janssen Pharmaceuticals Congenital Heart Disease Product and Solutions
Table 88. Janssen Pharmaceuticals Congenital Heart Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Medtronic Corporate Information, Location and Competitors
Table 90. Medtronic Congenital Heart Disease Major Business
Table 91. Medtronic Congenital Heart Disease Total Revenue (USD Million) (2017-2018)
Table 92. Medtronic SWOT Analysis
Table 93. Medtronic Congenital Heart Disease Product and Solutions
Table 94. Medtronic Congenital Heart Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Global Congenital Heart Disease Revenue (Million USD) by Players (2015-2020)
Table 96. Global Congenital Heart Disease Revenue Share by Players (2015-2020)
Table 97. Global Congenital Heart Disease Revenue (Million USD) by Regions (2015-2020)
Table 98. Global Congenital Heart Disease Revenue Market Share by Regions (2015-2020)
Table 99. North America Congenital Heart Disease Revenue by Countries (2015-2020)
Table 100. North America Congenital Heart Disease Revenue Market Share by Countries (2015-2020)
Table 101. Europe Congenital Heart Disease Revenue (Million USD) by Countries (2015-2020)
Table 102. Asia-Pacific Congenital Heart Disease Revenue (Million USD) by Countries (2015-2020)
Table 103. South America Congenital Heart Disease Revenue by Countries (2015-2020)
Table 104. South America Congenital Heart Disease Revenue Market Share by Countries (2015-2020)
Table 105. Middle East and Africa Congenital Heart Disease Revenue (Million USD) by Countries (2015-2020)
Table 106. Middle East and Africa Congenital Heart Disease Revenue Market Share by Countries (2015-2020)
Table 107. Global Congenital Heart Disease Revenue (Million USD) by Type (2015-2020)
Table 108. Global Congenital Heart Disease Revenue Share by Type (2015-2020)
Table 109. Global Congenital Heart Disease Revenue Forecast by Type (2021-2025)
Table 110. Global Congenital Heart Disease Revenue by Application (2015-2020)
Table 111. Global Congenital Heart Disease Revenue Share by Application (2015-2020)
Table 112. Global Congenital Heart Disease Revenue Forecast by Application (2021-2025)
Table 113. Global Congenital Heart Disease Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Congenital Heart Disease Picture
Figure 2. Global Congenital Heart Disease Revenue Market Share by Type in 2019
Figure 3. Medications Picture
Figure 4. Implantable heart devices Picture
Figure 5. Catheter procedures Picture
Figure 6. Open-heart surgery Picture
Figure 7. Heart transplant Picture
Figure 8. Congenital Heart Disease Revenue Market Share by Application in 2019
Figure 9. Hospitals and clinics Picture
Figure 10. Diagnostic centres Picture
Figure 11. Global Congenital Heart Disease Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Congenital Heart Disease Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Congenital Heart Disease Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Congenital Heart Disease Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Congenital Heart Disease Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Congenital Heart Disease Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Congenital Heart Disease Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Congenital Heart Disease Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Congenital Heart Disease Revenue Market Share in 2019
Figure 20. Global Top 10 Players Congenital Heart Disease Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Congenital Heart Disease Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Congenital Heart Disease Revenue Market Share by Regions (2015-2020)
Figure 24. Global Congenital Heart Disease Revenue Market Share by Regions in 2018
Figure 25. North America Congenital Heart Disease Revenue and Growth Rate (2015-2020)
Figure 26. Europe Congenital Heart Disease Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Congenital Heart Disease Revenue and Growth Rate (2015-2020)
Figure 28. South America Congenital Heart Disease Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Congenital Heart Disease Revenue and Growth Rate (2015-2020)
Figure 30. North America Congenital Heart Disease Revenue Market Share by Countries (2015-2020)
Figure 31. North America Congenital Heart Disease Revenue Market Share by Countries in 2019
Figure 32. USA Congenital Heart Disease Revenue and Growth Rate (2015-2020)
Figure 33. Canada Congenital Heart Disease Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Congenital Heart Disease Revenue and Growth Rate (2015-2020)
Figure 35. Europe Congenital Heart Disease Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Congenital Heart Disease Revenue Market Share by Countries in 2019
Figure 37. Germany Congenital Heart Disease Revenue and Growth Rate (2015-2020)
Figure 38. UK Congenital Heart Disease Revenue and Growth Rate (2015-2020)
Figure 39. France Congenital Heart Disease Revenue and Growth Rate (2015-2020)
Figure 40. Russia Congenital Heart Disease Revenue and Growth Rate (2015-2020)
Figure 41. Italy Congenital Heart Disease Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Congenital Heart Disease Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Congenital Heart Disease Revenue Market Share by Countries in 2019
Figure 44. China Congenital Heart Disease Revenue and Growth Rate (2015-2020)
Figure 45. Japan Congenital Heart Disease Revenue and Growth Rate (2015-2020)
Figure 46. Korea Congenital Heart Disease Revenue and Growth Rate (2015-2020)
Figure 47. India Congenital Heart Disease Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Congenital Heart Disease Revenue and Growth Rate (2015-2020)
Figure 49. South America Congenital Heart Disease Revenue Market Share by Countries (2015-2020)
Figure 50. South America Congenital Heart Disease Revenue Market Share by Countries in 2019
Figure 51. Brazil Congenital Heart Disease Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Congenital Heart Disease Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Congenital Heart Disease Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Congenital Heart Disease Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Congenital Heart Disease Revenue and Growth Rate (2015-2020)
Figure 56. UAE Congenital Heart Disease Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Congenital Heart Disease Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Congenital Heart Disease Revenue and Growth Rate (2015-2020)
Figure 59. Global Congenital Heart Disease Revenue Share by Type (2015-2020)
Figure 60. Global Congenital Heart Disease Revenue Share by Type in 2019
Figure 61. Global Congenital Heart Disease Market Share Forecast by Type (2021-2025)
Figure 62. Global Medications Revenue Growth Rate (2015-2020)
Figure 63. Global Implantable heart devices Revenue Growth Rate (2015-2020)
Figure 64. Global Catheter procedures Revenue Growth Rate (2015-2020)
Figure 65. Global Open-heart surgery Revenue Growth Rate (2015-2020)
Figure 66. Global Heart transplant Revenue Growth Rate (2015-2020)
Figure 67. Global Congenital Heart Disease Revenue Share by Application (2015-2020)
Figure 68. Global Congenital Heart Disease Revenue Share by Application in 2019
Figure 69. Global Congenital Heart Disease Market Share Forecast by Application (2021-2025)
Figure 70. Global Hospitals and clinics Revenue Growth Rate (2015-2020)
Figure 71. Global Diagnostic centres Revenue Growth Rate (2015-2020)
Figure 72. Global Congenital Heart Disease Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Congenital Heart Disease Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Congenital Heart Disease Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Congenital Heart Disease Revenue Market Forecast (2021-2025)
Figure 76. Europe Congenital Heart Disease Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Congenital Heart Disease Revenue Market Forecast (2021-2025)
Figure 78. South America Congenital Heart Disease Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Congenital Heart Disease Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
心構造疾患治療デバイスの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Structural Heart Disease Treatment Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The St…- 炎症性心疾患の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Inflammatory Heart Disease market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Inflammatory Heart…
- リウマチ性心疾患の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Rheumatic Heart Disease market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Rheumatic Heart Disea…
- 組織心臓弁材料の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Tissue Heart Valve Materials market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tissue Heart Val…
- 組織工学心臓弁の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Tissue Engineered Heart Valve market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tissue Engineer…